Insider Buying and Selling - MREO

Transaction	Filed	Name	Type	Shares @ Price	Value	Balance change		Ownership
09/13/2024	09/16/2024	Fox Christine Ann Chief Financial Officer CFO	Sell	-19,158 @ $4.22	($80,865.92)	89,285	(-17.67%)	Direct
09/13/2024	09/16/2024	Hughes-Wilson Alexandra Chief Patient Access and Commercial Planning Officer	Sell	-100,312 @ $4.22	($423,416.95)	50,475	(-66.53%)	Direct
09/13/2024	09/16/2024	Lewicki John A. Chief Scientific Officer Officer	Sell	-10,937 @ $4.22	($46,165.08)	78,630	(-12.21%)	Direct
09/13/2024	09/16/2024	Scots-Knight Denise Chief Executive Officer CEO Director	Sell	-60,046 @ $4.22	($253,454.17)	808,921	(-6.91%)	Direct
09/13/2024	09/16/2024	Sermon Charles General Counsel Officer	Sell	-20,946 @ $4.22	($88,413.07)	219,061	(-8.73%)	Direct
09/12/2024	09/16/2024	Fox Christine Ann Chief Financial Officer CFO	Sell	-9,128 @ $4.47	($40,826.81)	108,443	(-7.76%)	Direct
09/12/2024	09/16/2024	Hughes-Wilson Alexandra Chief Patient Access and Commercial Planning Officer	Sell	-47,798 @ $4.47	($213,786.11)	150,787	(-24.07%)	Direct
09/12/2024	09/16/2024	Lewicki John A. Chief Scientific Officer Officer	Sell	-5,212 @ $4.47	($23,311.71)	89,567	(-5.50%)	Direct
09/12/2024	09/16/2024	Scots-Knight Denise Chief Executive Officer CEO Director	Sell	-28,611 @ $4.47	($127,968.42)	868,967	(-3.19%)	Direct
09/12/2024	09/16/2024	Sermon Charles General Counsel Officer	Sell	-9,980 @ $4.47	($44,637.55)	240,007	(-3.99%)	Direct

Mereo Biopharma Group plc - MREO